EcoDrugPlus

Ensembl ID : ENSOMYG00000014379
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSOMYG00000015926
Gene Symbol: -
Cross references: -
144 Possible Orthologues:

Ensembl ID : ENSOMYG00000037426
Gene Symbol: -
Cross references: -
195 Possible Orthologues:

Ensembl ID : ENSOMYG00000037361
Gene Symbol: -
Cross references: -
206 Possible Orthologues:

Ensembl ID : ENSOMYG00000034199
Gene Symbol: -
Cross references: -
159 Possible Orthologues:

Ensembl ID : ENSOMYG00000017774
Gene Symbol: -
Cross references: -
178 Possible Orthologues:

Ensembl ID : ENSOMYG00000017923
Gene Symbol: -
Cross references: -
215 Possible Orthologues:

Ensembl ID : ENSOMYG00000017996
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSOMYG00000017926
Gene Symbol: -
Cross references: -
16 Possible Orthologues:

Ensembl ID : ENSOMYG00000019523
Gene Symbol: -
Cross references: -
197 Possible Orthologues:

Ensembl ID : ENSOMYG00000019560
Gene Symbol: -
Cross references: -
500 Possible Orthologues:

Ensembl ID : ENSOMYG00000019653
Gene Symbol: -
Cross references: -
247 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).